NCT07089576 - Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA | Biotech Hunter

Enrollment

132

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

June 30, 2032

Conditions

Aortic Arch AneurysmAortic Arch DissectionChronic Aortic DissectionAcute Aortic Dissection

Interventions

DEVICE

Arcevo™ LSA Hybrid Stent Graft System

The Arcevo LSA Hybrid Stent Graft System is an implantable aortic stent graft with LSA branch which is preloaded onto a delivery system and implanted during an open surgical procedure, or more specifically a total arch replacement procedure. The device is intended for use with a proximal surgical graft (not supplied). If additional coverage is needed, a protocol specified thoracic endovascular aortic repair (TEVAR) device may be used.

Trial Locations (1)

44195

Cleveland Clinic Foundation, Cleveland